Categories: Business

J&J looks to buy Ollin Biosciences for up to $3.4 billion, FT says

Nov 15 (Reuters) – Johnson & Johnson could announce a deal as soon as Monday to buy Texas-based biotech Ollin Biosciences for up to $3.4 billion, the Financial Times said, citing people familiar with

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Indianews Syndication

Recent Posts

Japan's Nikkei sinks under weight of tech shares in big week for AI

TOKYO, Nov 16 (Reuters) - Japan's Nikkei share average slumped on Monday, dragged down by…

3 minutes ago

Japan's economy unexpectedly shrinks as inflation squeezes households

By Makiko Yamazaki and Satoshi Sugiyama TOKYO, Nov 16 (Reuters) - Japan's economy unexpectedly shrank…

6 minutes ago

CHINA STATS BUREAU SPOKESPERSON: POSITIVE CHANGES IN CHINA'S PROPERTY MARKET, BUT MARKETS IN SOME REGIONS ARE STILL FACE PRESSURE

CHINA STATS BUREAU SPOKESPERSON: POSITIVE CHANGES IN CHINA'S PROPERTY MARKET, BUT MARKETS IN SOME REGIONS…

10 minutes ago

VEGOILS-Palm opens lower on weaker rival oils, crude

KUALA LUMPUR, Nov 16 (Reuters) - Malaysian palm oil futures opened lower on Monday, snapping…

13 minutes ago

Jalen Brunson’s late OT trey caps Knicks’ rally past Raptors

Jalen Brunson hit the tie-breaking 3-pointer with 33 seconds left in overtime for the visiting…

20 minutes ago

UPDATE 1-China's October crude steel output falls on weak demand, thin margins

(Adds details, background from paragraph 2) Nov 16 (Reuters) - China's crude steel output fell…

25 minutes ago